Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits

Barrett, 2014, Chimeric antigen receptor therapy for cancer, Annu. Rev. Med., 65, 333, 10.1146/annurev-med-060512-150254

Barrett, 2014, Toxicity management for patients receiving novel T-cell engaging therapies, Curr. Opin. Pediatr., 26, 43, 10.1097/MOP.0000000000000043

Brentjens, 2013, CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia, Sci. Transl. Med., 5, 177ra38, 10.1126/scitranslmed.3005930

Dotti, 2014, Design and development of therapies using chimeric antigen receptor-expressing T cells, Immunol. Rev., 257, 107, 10.1111/imr.12131

Fedorov, 2013, PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses, Sci. Transl. Med., 5, 215ra172, 10.1126/scitranslmed.3006597

Fridy, 2014, A robust pipeline for rapid production of versatile nanobody repertoires, Nat. Methods, 11, 1253, 10.1038/nmeth.3170

Gordon, 2015, Mechanical Allostery: Evidence for a Force Requirement in the Proteolytic Activation of Notch, Dev. Cell, 33, 729, 10.1016/j.devcel.2015.05.004

Grupp, 2013, Chimeric antigen receptor-modified T cells for acute lymphoid leukemia, N. Engl. J. Med., 368, 1509, 10.1056/NEJMoa1215134

June, 2009, Engineering lymphocyte subsets: tools, trials and tribulations, Nat. Rev. Immunol., 9, 704, 10.1038/nri2635

Kloss, 2013, Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells, Nat. Biotechnol., 31, 71, 10.1038/nbt.2459

Lamers, 2006, Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience, J. Clin. Oncol., 24, e20, 10.1200/JCO.2006.05.9964

Lienert, 2014, Synthetic biology in mammalian cells: next generation research tools and therapeutics, Nat. Rev. Mol. Cell Biol., 15, 95, 10.1038/nrm3738

Lim, 2010, Designing customized cell signalling circuits, Nat. Rev. Mol. Cell Biol., 11, 393, 10.1038/nrm2904

Morgan, 2010, Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2, Mol. Ther., 18, 843, 10.1038/mt.2010.24

Morgan, 2013, Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy, J. Immunother., 36, 133, 10.1097/CJI.0b013e3182829903

Morsut, 2016, Engineering customized cell sensing and response behaviors using synthetic notch receptors, Cell, 164, 780, 10.1016/j.cell.2016.01.012

Porter, 2011, Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia, N. Engl. J. Med., 365, 725, 10.1056/NEJMoa1103849

Rabinovich, 2008, Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer, Proc. Natl. Acad. Sci. USA, 105, 14342, 10.1073/pnas.0804105105

Sadelain, 2009, The promise and potential pitfalls of chimeric antigen receptors, Curr. Opin. Immunol., 21, 215, 10.1016/j.coi.2009.02.009

Wilkie, 2012, Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling, J. Clin. Immunol., 32, 1059, 10.1007/s10875-012-9689-9